Newark Beth Israel Medical Center, an RWJBarnabas Health facility, now offers heart attack patients a minimally invasive, “cutting-edge” cardiac treatment. The health care provider announced Nov. 29 ...
Henry Mayo Newhall Hospital is one of the first hospitals in Southern California to improve treatment of "widowmaker" heart ...
CHELMSFORD, Mass., October 29, 2024--ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today the results of two important studies evaluating the ...
Results of a clinical trial demonstrate that an infusion of blood that is "supersaturated" with oxygen (SS02) can reduce the amount of damaged heart muscle immediately following a life-threatening ...
In a milestone achievement, the NCH Rooney Heart Institute is at the forefront of innovation in healthcare to improve treatment for the dreaded “widow-maker” heart attacks with the introduction of ...
ZOLL Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that the Centers for Medicare & Medicaid Services (CMS) ICD-10 Coordination ...
REGISTER for free or LOG IN to view this content Coronary ...
ATTR-CM is a serious and underrecognized cause of heart failure. This program will help raise awareness of the signs and symptoms of ATTR-CM, the role of cardiac health professionals in diagnosis, and ...
Supersaturated oxygen (SSO2) administered during catheter-based treatments for heart attack can significantly reduce heart muscle damage, according to a new study reported in Circulation: ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results